-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Cuts Oxford Biomedica PT, Keeps Buy Rating

MT Newswires·11/13/2026 08:41:20
Listen to the news
08:41 AM EST, 11/13/2026 (MT Newswires) -- Jefferies on Friday lowered the price target for British gene and cell therapy company Oxford Biomedica (OXB.L) to 7.16 pounds sterling from 8.27 pounds and affirmed its buy rating. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)